Guidelines on the use of irradiated blood components episode artwork

EPISODE · Feb 19, 2021 · 13 MIN

Guidelines on the use of irradiated blood components

from The BSH Guidelines Official Podcast · host British Society for Haematology

Dr Paula Bolton Maggs presents the podcast on the Guidelines on the use of irradiated blood components. To provide healthcare professionals with clear guidance on situations when the use of irradiated blood components is indicated. The term ‘blood component’ means the therapeutic constituents of human blood (red cells, white cells, platelets and plasma) that can be prepared by various methods (JPAC https://www.transfusionguidelines.org/red‐book/definitions). The multidisciplinary writing group developed evidence‐based clarification and practical guidance in clinical areas of ambiguity. Publications relating to patients of all age groups have been assessed. The guidance may not be appropriate in all patient situations and assessment of individual circumstances with the appropriate risk assessments and patient involvement may lead to alternative decisions. Dr Bolton Maggs discusses the guideline in three parts but also, stresses that the podcast is not a substitute for reading the guideline: 1) Background on the use of irradiation and new evidence on aetiology of transfusion - associated - graft - versus - disease. 2) Specific issues for Hodgins and non Hodgins lymphoma 3) Summary of the changes for paediatric transfusion Dr Bolton- Maggs has recently retired as a Consultant Haematologist and Director of Serious Hazards of Transfusion (SHOT).

Dr Paula Bolton Maggs presents the podcast on the Guidelines on the use of irradiated blood components. To provide healthcare professionals with clear guidance on situations when the use of irradiated blood components is indicated. The term ‘blood component’ means the therapeutic constituents of human blood (red cells, white cells, platelets and plasma) that can be prepared by various methods (JPAC https://www.transfusionguidelines.org/red‐book/definitions). The multidisciplinary writing group developed evidence‐based clarification and practical guidance in clinical areas of ambiguity. Publications relating to patients of all age groups have been assessed. The guidance may not be appropriate in all patient situations and assessment of individual circumstances with the appropriate risk assessments and patient involvement may lead to alternative decisions. Dr Bolton Maggs discusses the guideline in three parts but also, stresses that the podcast is not a substitute for reading the guideline: 1) Background on the use of irradiation and new evidence on aetiology of transfusion - associated - graft - versus - disease. 2) Specific issues for Hodgins and non Hodgins lymphoma 3) Summary of the changes for paediatric transfusion Dr Bolton- Maggs has recently retired as a Consultant Haematologist and Director of Serious Hazards of Transfusion (SHOT).

NOW PLAYING

Guidelines on the use of irradiated blood components

0:00 13:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BSH Guidelines Official Podcast?

This episode is 13 minutes long.

When was this The BSH Guidelines Official Podcast episode published?

This episode was published on February 19, 2021.

What is this episode about?

Dr Paula Bolton Maggs presents the podcast on the Guidelines on the use of irradiated blood components. To provide healthcare professionals with clear guidance on situations when the use of irradiated blood components is indicated. The term ‘blood...

Can I download this The BSH Guidelines Official Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!